Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NEMOLIZUMAB-ILTO for Dermatitis atopic: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 1,596 adverse event reports in the FDA FAERS database where NEMOLIZUMAB-ILTO was used for Dermatitis atopic.

Most Reported Side Effects for NEMOLIZUMAB-ILTO

Side Effect Reports % Deaths Hosp.
Inappropriate schedule of product administration 826 19.8% 0 7
Product dose omission issue 792 18.9% 0 12
Device malfunction 761 18.2% 0 1
Incorrect dose administered 579 13.8% 0 1
Pruritus 416 10.0% 0 9
Rash 263 6.3% 1 5
Headache 181 4.3% 0 3
Drug ineffective 158 3.8% 0 2
Device leakage 153 3.7% 0 1
Device use issue 120 2.9% 0 0
Dermatitis atopic 117 2.8% 0 0
Neurodermatitis 109 2.6% 0 2
Eczema 108 2.6% 0 0
Dry skin 105 2.5% 0 1
Erythema 88 2.1% 0 5

Other Indications for NEMOLIZUMAB-ILTO

Neurodermatitis (1,765) Product used for unknown indication (658) Eczema (99) Pruritus (30) Psoriasis (11) Dermatitis (7) Rash (5) Urticaria (5)

Other Drugs Used for Dermatitis atopic

DUPILUMAB (179,563) UPADACITINIB (5,263) TRALOKINUMAB-LDRM (3,007) CRISABOROLE (2,139) ABROCITINIB (1,616) RUXOLITINIB (740) TACROLIMUS (515) METHOTREXATE (400) CYCLOSPORINE (370) LEBRIKIZUMAB-LBKZ (312)

Related Pages

NEMOLIZUMAB-ILTO Full Profile All Dermatitis atopic Drugs NEMOLIZUMAB-ILTO Demographics NEMOLIZUMAB-ILTO Timeline